KALA BIO, Inc. (KALA)
KALA Stock Price Chart
Explore KALA BIO, Inc. interactive price chart. Choose custom timeframes to analyze KALA price movements and trends.
KALA Company Profile
Discover essential business fundamentals and corporate details for KALA BIO, Inc. (KALA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
20 Jul 2017
Employees
38.00
Website
https://www.kalarx.comCEO
Avi Minkowitz
Description
Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the creation and commercialization of new therapeutic solutions. The core of their strategy involves utilizing proprietary nanoparticle technology, specifically mucus penetrating particles (MPPs). Initially, their focus for these treatments is directed towards ophthalmic diseases. The company was established in 2009 by co-founders Justin Hanes, Robert S. Langer, and Colin R. Gardner, and its headquarters are located in Arlington, Massachusetts.
KALA Financial Timeline
Browse a chronological timeline of KALA BIO, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
KALA Stock Performance
Access detailed KALA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
